Respiratory Therapy: Antiallergics, Antipyretics, Anti Cold/Cough

MILDRESP LS

Ambroxol HCl 30mg + Levosalbutamol 1mg + Guaiphenesin 50mg per 5mL

Dosage Form Syrup

Packing 100ML (with carton)

MRP ₹120

Prescribed By Pulmonologist, Paediatrician, General Physician, ENT Specialist, Chest Physician

Enquire on WhatsApp Contact Us

Quick Facts

Storage Below 30°C; Shake before use; Schedule: H; MRP: ₹120; 100mL with carton

Key Benefits

Levosalbutamol — bronchodilator with fewer cardiac side effects than plain Salbutamol

Ambroxol + Guaiphenesin — dual mucolytic-expectorant combination

100mL economy — adequate for longer treatment courses

Preferred in paediatric and elderly patients

With carton for retail presentation

Mechanism of Action

Similar triple-action to MILDRESP AM but uses Levosalbutamol instead of Terbutaline as the bronchodilator. Levosalbutamol is the active L-isomer of Salbutamol — it provides bronchodilation with fewer cardiac side effects (less tachycardia and tremors) than racemic Salbutamol. This makes it better tolerated in children and elderly patients.

Indications

Productive cough with bronchospasm in children and elderly, asthma with mucus, bronchitis, and patients where Salbutamol causes significant palpitations.

Dosage & Administration

Take as prescribed by your doctor or healthcare professional. Do not self-medicate.

Why MILDRESP LS?

The Levosalbutamol-based variant of MILDRESP AM — better tolerated in children and cardiac-sensitive patients where Terbutaline may cause more tremor.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.